JAK2基因第12外显子真性红细胞增多症的长期随访：一项法国骨髓增殖性肿瘤协作组（FIM）研究 - Suppr

Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.

作者信息

Tondeur Sylvie, Paul Franciane, Riou Jérémie, Mansier Olivier, Ranta Dana, Le Clech Lenaïg, Lippert Eric, Tavitian Suzanne, Chaoui Driss, Mercier Mélanie, De Renzis Benoit, Cottin Laurane, Cassinat Bruno, Chrétien Jean-Marie, Ianotto Jean-Christophe, Allangba Olivier, Marzac Christophe, Voillat Laurent, Boyer Françoise, Orvain Corentin, Hunault-Berger Mathilde, Girodon François, Kiladjian Jean-Jacques, Ugo Valérie, Luque Paz Damien

机构信息

CHU Grenoble, Laboratoire de Génétique des hémopathies, Institut de Biologie et Pathologie, Grenoble, France.

CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, Grenoble, France.

出版信息

Leukemia. 2021 Mar;35(3):871-875. doi: 10.1038/s41375-020-0991-x. Epub 2020 Jul 21.

DOI:10.1038/s41375-020-0991-x

PMID:32694617

Abstract

摘要

相似文献

Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.

Leukemia. 2021 Mar;35(3):871-875. doi: 10.1038/s41375-020-0991-x. Epub 2020 Jul 21.

Low frequency of JAK2 exon 12 mutations in classic and atypical CMPDs.

Leuk Res. 2008 Sep;32(9):1485-7. doi: 10.1016/j.leukres.2008.01.002. Epub 2008 Mar 4.

Aquagenic pruritus and the JAK2 V617F mutation.

Clin Exp Dermatol. 2019 Apr;44(3):e33. doi: 10.1111/ced.13872. Epub 2018 Dec 21.

[Not Available].

Praxis (Bern 1994). 2017 Jul;106(15):807-813. doi: 10.1024/1661-8157/a002740.

Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations.

Asian Pac J Cancer Prev. 2019 Jan 25;20(1):41-44. doi: 10.31557/APJCP.2019.20.1.41.

Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation.

Leuk Res. 2023 Apr;127:107033. doi: 10.1016/j.leukres.2023.107033. Epub 2023 Feb 8.

[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].

Orv Hetil. 2011 Nov 6;152(45):1795-803. doi: 10.1556/OH.2011.29226.

Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis.

Jpn J Clin Oncol. 2009 Aug;39(8):509-13. doi: 10.1093/jjco/hyp048. Epub 2009 Jun 2.

[Myeloproliferative diseases caused by JAK2 mutation].

Rinsho Byori. 2009 Apr;57(4):357-64.

An increase in diagnostic JAK2 V617F mutation testing: Is masked polycythaemia vera the explanantion?

Eur J Intern Med. 2018 Jun;52:e37-e38. doi: 10.1016/j.ejim.2018.03.017. Epub 2018 Apr 3.

引用本文的文献

Diagnosis- and Prognosis-Related Gene Alterations in -Negative Myeloproliferative Neoplasms.

Int J Mol Sci. 2023 Aug 21;24(16):13008. doi: 10.3390/ijms241613008.

JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.

J Cancer Res Clin Oncol. 2023 Jul;149(8):4789-4803. doi: 10.1007/s00432-022-04327-0. Epub 2022 Oct 15.

Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study.

Int J Hematol. 2022 Nov;116(5):696-711. doi: 10.1007/s12185-022-03412-x. Epub 2022 Jul 9.

Genetic Background of Polycythemia Vera.

Genes (Basel). 2022 Apr 2;13(4):637. doi: 10.3390/genes13040637.

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.

Blood Cancer J. 2021 Sep 17;11(9):154. doi: 10.1038/s41408-021-00552-x.

Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.

Leukemia. 2021 Dec;35(12):3339-3351. doi: 10.1038/s41375-021-01401-3. Epub 2021 Sep 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.

Leukemia. 2021 Mar;35(3):871-875. doi: 10.1038/s41375-020-0991-x. Epub 2020 Jul 21.

Low frequency of JAK2 exon 12 mutations in classic and atypical CMPDs.

Leuk Res. 2008 Sep;32(9):1485-7. doi: 10.1016/j.leukres.2008.01.002. Epub 2008 Mar 4.

Aquagenic pruritus and the JAK2 V617F mutation.

Clin Exp Dermatol. 2019 Apr;44(3):e33. doi: 10.1111/ced.13872. Epub 2018 Dec 21.

[Not Available].

Praxis (Bern 1994). 2017 Jul;106(15):807-813. doi: 10.1024/1661-8157/a002740.

Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations.

Asian Pac J Cancer Prev. 2019 Jan 25;20(1):41-44. doi: 10.31557/APJCP.2019.20.1.41.

Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation.

Leuk Res. 2023 Apr;127:107033. doi: 10.1016/j.leukres.2023.107033. Epub 2023 Feb 8.

[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].

Orv Hetil. 2011 Nov 6;152(45):1795-803. doi: 10.1556/OH.2011.29226.

Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis.

Jpn J Clin Oncol. 2009 Aug;39(8):509-13. doi: 10.1093/jjco/hyp048. Epub 2009 Jun 2.

[Myeloproliferative diseases caused by JAK2 mutation].

Rinsho Byori. 2009 Apr;57(4):357-64.

An increase in diagnostic JAK2 V617F mutation testing: Is masked polycythaemia vera the explanantion?

Eur J Intern Med. 2018 Jun;52:e37-e38. doi: 10.1016/j.ejim.2018.03.017. Epub 2018 Apr 3.

引用本文的文献

Diagnosis- and Prognosis-Related Gene Alterations in -Negative Myeloproliferative Neoplasms.

Int J Mol Sci. 2023 Aug 21;24(16):13008. doi: 10.3390/ijms241613008.

JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.

J Cancer Res Clin Oncol. 2023 Jul;149(8):4789-4803. doi: 10.1007/s00432-022-04327-0. Epub 2022 Oct 15.

Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study.

Int J Hematol. 2022 Nov;116(5):696-711. doi: 10.1007/s12185-022-03412-x. Epub 2022 Jul 9.

Genetic Background of Polycythemia Vera.

Genes (Basel). 2022 Apr 2;13(4):637. doi: 10.3390/genes13040637.

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.

Blood Cancer J. 2021 Sep 17;11(9):154. doi: 10.1038/s41408-021-00552-x.

Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.

Leukemia. 2021 Dec;35(12):3339-3351. doi: 10.1038/s41375-021-01401-3. Epub 2021 Sep 3.

Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献